Molecular Biomarkers in the Cerebrospinal Fluid in Multiple Sclerosis

被引：0

作者：

Shedko E.D. ^{[1
]}

Tyumentseva M.A. ^{[1
]}

机构：

[1] Central Research Institute of Epidemiology, Russian Federal Service for Surveillance of Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor), Moscow

来源：

Neuroscience and Behavioral Physiology | 2020年 / 50卷 / 5期

关键词：

autoimmune diseases; biomarkers; cerebrospinal fluid; multiple sclerosis;

D O I：

10.1007/s11055-020-00932-z

中图分类号：

学科分类号：

摘要：

Multiple sclerosis (MS) is a chronic autoimmune disease affecting the spinal cord and brain. Detection of the disease at its initial stages is a difficult task as the causes and mechanisms of the manifestations of the disease remain unclear. Diagnosis of MS is a complex process. Studies of the molecular mechanisms of the disease and the search for biomarkers are among the key directions in the diagnosis of the disease. This review addresses potential biomarkers for multiple sclerosis detected in the cerebrospinal fluid. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.

引用

页码：527 / 533

页数：6

共 50 条

[31] Cerebrospinal fluid in Multiple Sclerosis
Arasa, F.
FORTSCHRITTE DER NEUROLOGIE UND PSYCHIATRIE UND IHRER GRENZGEBIETE, 1950, 18 (02): : 85 - 105
[32] The cerebrospinal fluid in multiple sclerosis
Moore, JE
ARCHIVES OF INTERNAL MEDICINE, 1920, 25 (01) : 58 - 62
[33] MULTIPLE SCLEROSIS AND CEREBROSPINAL FLUID
TOURTELLOTTE, WW
MEDICAL CLINICS OF NORTH AMERICA, 1963, 47 (06) : 1619 - &
[34] THE CEREBROSPINAL FLUID IN MULTIPLE SCLEROSIS
FREEDMAN, DA
MERRITT, HH
RESEARCH PUBLICATIONS-ASSOCIATION FOR RESEARCH IN NERVOUS AND MENTAL DISEASE, 1948, 28 : 428 - 439
[35] Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
Novakova, Lenka
Axelsson, Markus
Khademi, Mohsen
Zetterberg, Henrik
Blennow, Kaj
Malmestrom, Clas
Piehl, Fredrik
Olsson, Tomas
Lycke, Jan
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 62 - 71
[36] Aptamer-based screening of cerebrospinal fluid for protein biomarkers of multiple sclerosis
Soomro, Sanam
Hughes, Samuel
Greenberg, Benjamin
Hanly, John
Mohan, Chandra
JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
[37] Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis
Astrid Guldbrandsen
Ragnhild Reehorst Lereim
Mari Jacobsen
Hilde Garberg
Ann Cathrine Kroksveen
Harald Barsnes
Frode S. Berven
Clinical Proteomics, 2020, 17
[38] Identification of Biomarkers in Cerebrospinal Fluid and Serum of Multiple Sclerosis Patients by Immunoproteomics Approach
Colomba, Paolo
Fontana, Simona
Salemi, Giuseppe
Barranca, Marilisa
Lo Sicco, Claudia
Mazzola, Maria Antonietta
Ragonese, Paolo
Savettieri, Giovanni
De Leo, Giacomo
Alessandro, Riccardo
Duro, Giovanni
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (12): : 23269 - 23282
[39] Proteomics-Based Technologies in the Discovery of Biomarkers for Multiple Sclerosis in the Cerebrospinal Fluid
Lourenco, A. S. T.
Baldeiras, I.
Graos, M.
Duarte, C. B.
CURRENT MOLECULAR MEDICINE, 2011, 11 (04) : 326 - 349
[40] An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis
Pieragostino, Damiana
D'Alessandro, Michele
di Ioia, Maria
Rossi, Claudia
Zucchelli, Mirco
Urbani, Andrea
Di Ilio, Carmine
Lugaresi, Alessandra
Sacchetta, Paolo
Del Boccio, Piero
MOLECULAR BIOSYSTEMS, 2015, 11 (06) : 1563 - 1572

← 1 2 3 4 5 →